共 50 条
- [43] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes [J]. DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 788 - 805
- [45] Effects of glucagon-like peptide-1 receptor agonists on fluid intake in healthy volunteers [J]. Endocrine, 2020, 70 : 292 - 298
- [46] Can epicardial fat glucagon-like peptide-1 receptor open up to the cardiovascular benefits of glucagon-like peptide-1 analogues? [J]. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (03): : 224 - 225